How diabetes drug metformin prevents, suppresses cancer growth
Ancient genetic pathway suggests new ways to fight cancers and support healthy aging
December 16, 2016
A team of Massachusetts General Hospital (MGH) and Harvard Medical School investigators has identified a pathway that appears to underlie the apparent ability of the diabetes drug metformin to both block the growth of human cancer cells and extend the lifespan of the C.elegans roundworm.
That finding implies that this single genetic pathway may play an important role in a wide range of organisms — including humans.
“We… read more
